Arcutis Biotherapeutics (ARQT) Enterprise Value (2019 - 2026)
Arcutis Biotherapeutics (ARQT) posted quarterly Enterprise Value of -$189.5 million for Q1 2026, down 30.18% year-over-year from -$271.5 million in Q1 2025, and up 14.23% quarter-over-quarter from -$221.0 million in Q4 2025.
Arcutis Biotherapeutics (ARQT) Enterprise Value (2019 - 2026) Analysis & Trends
Arcutis Biotherapeutics' Enterprise Value history runs 8 years deep, the most recent figure standing at -$189.5 million for Q1 2026.
- In Q1 2026, Enterprise Value fell 30.18% year-over-year to -$189.5 million; the TTM figure through Mar 2026 stood at -$189.5 million (down 30.18% YoY), while the FY2025 annual figure was -$221.0 million, up 3.06% from the prior year.
- Enterprise Value for Q1 2026 stood at -$189.5 million, up from -$221.0 million in the prior quarter.
- The five-year high for Enterprise Value was -$118.4 million in Q2 2025, with the low at -$396.7 million in Q3 2022.
- The 5-year median for Enterprise Value is -$221.0 million (2025), against an average of -$232.3 million.
- The sharpest annual moves came in 2023 and 2024: Enterprise Value soared 69.61% in 2023, then tumbled 174.23% in 2024.
- Arcutis Biotherapeutics' Enterprise Value stood at -$357.2 million in 2022, then soared by 48.38% to -$184.4 million in 2023, then declined by 23.63% to -$228.0 million in 2024, then rose by 3.06% to -$221.0 million in 2025, then grew by 14.23% to -$189.5 million in 2026.
- Business Quant data shows ARQT's Enterprise Value at -$189.5 million in Q1 2026, -$221.0 million in Q4 2025, and -$191.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -7.99 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | -5.18 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -3.94 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | -5.10 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -8.46 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 2.12 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -3.31 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -1.16 Bn |
| 10 | Arcutis Biotherapeutics | 3.29 Bn | 3.05 Bn | 118.92 Mn | -238.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -238.55 Mn |
| Mar 31, 2026 | -189.55 Mn |
| Dec 31, 2025 | -220.98 Mn |
| Sep 30, 2025 | -191.07 Mn |
| Jun 30, 2025 | -118.38 Mn |
| Mar 31, 2025 | -145.60 Mn |
| Dec 31, 2024 | -227.96 Mn |
| Sep 30, 2024 | -330.56 Mn |
| Jun 30, 2024 | -278.78 Mn |
| Mar 31, 2024 | -214.37 Mn |
| Dec 31, 2023 | -184.39 Mn |
| Sep 30, 2023 | -120.54 Mn |
| Jun 30, 2023 | -164.46 Mn |
| Mar 31, 2023 | -251.90 Mn |
| Dec 31, 2022 | -357.18 Mn |
| Sep 30, 2022 | -396.65 Mn |
| Jun 30, 2022 | -282.17 Mn |
| Mar 31, 2022 | -275.01 Mn |
| Dec 31, 2021 | -292.15 Mn |
| Sep 30, 2021 | -367.27 Mn |